Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1995
11/08/1995EP0680334A1 Morphogen treatment of gastrointestinal ulcers
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0680258A1 Aprotinin and synergistic combinations thereof with lectins as larvicides against insect pests of agronomic crops, harvested material thereof, and products obtained from the harvested material
11/08/1995EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
11/08/1995EP0412149B1 Use of il-7 in providing medications for stimulation of platelet production
11/08/1995EP0373181B1 Novel coenzyme independent l-sorbosone dehydrogenase
11/08/1995CN1111455A Peptide inhibitors of mitogenesis and motorgenesis
11/08/1995CN1111158A Products containing G-CSF and TNF binding protein
11/07/1995US5464943 Fibroblast growth factor
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464938 Isolated viral protein TNF antagonists
11/07/1995US5464937 Type II Interleukin-1 receptors
11/07/1995US5464936 Compositions for identification of papillomavirus replication inhibitors
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464934 Metal chelates as spacer compounds in biologically active peptides
11/07/1995US5464933 Synthetic peptide inhibitors of HIV transmission
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464820 Specific inhibitors of tissue kallikrein
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/07/1995US5464818 From clostridium
11/07/1995US5464817 Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
11/07/1995US5464814 Polymerized, pyridoxylated hemoglobin
11/07/1995US5464778 Glycoprotein ligand for P-selectin and methods of use thereof
11/07/1995US5464774 DNA sequence
11/07/1995US5464770 Artificial sweeteners
11/07/1995US5464764 Method for enriching transformed murine embryonic stem cell containing modification in target DNA sequence in genome of cell
11/07/1995US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques
11/07/1995US5464758 Polynucleotide molecule codes for eukarotic proteins
11/07/1995US5464757 Corticotropin releasing factor, genetic engineering
11/07/1995US5464756 Processes and compositions for the isolation of human relaxin
11/07/1995US5464751 Purified protein or fragment bindable with p185, translation product of neu oncogene; dimer or trimer of protein; screening for mammalian tumor with p185 on tumor cell surfaces by contacting cells with protein, detecting bound protein
11/07/1995US5464745 Protein ligand binding region mapping system
11/07/1995US5464634 Red blood cell surrogate
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/03/1995CA2143923A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/02/1995WO1995029404A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
11/02/1995WO1995029259A1 Method and means for detecting and treating disorders in the blood coagulation cascade
11/02/1995WO1995029248A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO)
11/02/1995WO1995029247A1 Regulatory element conferring tapetum specificity
11/02/1995WO1995029245A2 Btf2 complex proteins and uses thereof
11/02/1995WO1995029244A1 Method to increase regulatory molecule production
11/02/1995WO1995029243A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029240A1 Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029238A1 Genetic sequences conferring disease resistance in plants and uses therefor
11/02/1995WO1995029237A1 Cardiotrophin and uses therefor
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029235A1 Spider neurotoxins and method of producing the same
11/02/1995WO1995029234A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995WO1995029233A1 ISOLATED NUCLEIC ACID MOLECULE CODING FOR FIBROBLAST ACTIVATION PROTEIN α AND USES THEREOF
11/02/1995WO1995029195A1 Ubiquitin-based split protein sensor
11/02/1995WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995029192A1 Thymidine kinase tk1, peptide, corresponding antibodies and use of these in determination of tumor proliferation
11/02/1995WO1995029191A1 Peptide fragments and analogs derived from pban 1-33 nh2 for controlling moths
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029189A1 FACTOR Xa INHIBITORS
11/02/1995WO1995029188A1 Human sperm diagnostic
11/02/1995WO1995028959A1 MICE MUTANT FOR Fc RECEPTORS AND METHOD OF TREATING AUTOIMMUNE DISEASE
11/02/1995WO1995028958A1 Induction of cytotoxic t lymphocytes (ctl) using antigenic peptides and a suitable adjuvant
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995WO1995028948A1 Compositions comprising dna damaging agents and p53
11/02/1995WO1995028946A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
11/02/1995WO1995028915A1 Red blood cell surrogate
11/02/1995WO1995028907A2 Megapoietin: a novel megakaryocyte growth promoting factor
11/02/1995WO1995028832A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/02/1995WO1995027060A3 Biologically active eph family ligands
11/02/1995WO1995026410A3 Biological insect control agent
11/02/1995EP0679718A2 Process for producing alpha-interferon
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679716A1 Gene signature
11/02/1995EP0679659A1 Cathepsin-l-specific inhibitor polypeptide
11/02/1995EP0679658A1 Endothelin-antagonizing peptide
11/02/1995EP0679259A1 Diagnosis of leishmaniasis
11/02/1995EP0679192A1 Improved recombinant production of proteins having factor viii:c activity
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679185A1 Ras associated gap proteins
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679162A1 Thrombus detection using radiolabelled disintegrins
11/02/1995EP0679095A1 Modified insulin-like growth factors
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995EP0679091A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995EP0679088A1 Pulmonary delivery of active fragments of parathyroid hormone
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995EP0517833B1 Regeneration and genetic transformation of sugar beet
11/02/1995EP0404967B1 Recombinant c-terminal alpha-amidating enzyme of human thyroid origin
11/02/1995DE4426453C1 New fusion protein contg. fragments of two cytomegalovirus antigens
11/02/1995DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft